Oxytocin Therapy in Southlake, TX
Oxytocin is produced in the hypothalamus and released by the posterior pituitary — it drives bonding, trust, emotional connection, and sexual responsiveness in both men and women. Most people know it as the "love hormone" and stop there. The clinical picture is considerably more nuanced: oxytocin modulates anxiety, social cognition, orgasm intensity, sexual desire, and the subjective experience of intimacy in ways that make it one of the most interesting targets in hormone optimization medicine. At Magnolia Functional Wellness, Dr. Farhan Abdullah prescribes compounded intranasal oxytocin as part of a broader hormone optimization evaluation — not as a standalone quick fix, but as a clinically considered addition to the right patient's protocol.
Learn More About
Oxytocin
.svg)
What is
Oxytocin
Oxytocin is a nine-amino-acid peptide hormone synthesized in magnocellular neurons of the hypothalamic paraventricular and supraoptic nuclei and released from the posterior pituitary into systemic circulation. It also acts as a neurotransmitter within the brain through local release at axon terminals in limbic, cortical, and brainstem regions — which is what makes its behavioral and psychological effects so distinct from purely peripheral hormones.
In the periphery, oxytocin drives uterine contractions during labor, milk ejection during breastfeeding, and plays established roles in pair bonding and parental behavior across mammalian species. Centrally, it's considerably more complex. Oxytocin modulates the amygdala's fear and threat-detection circuitry — reducing its reactivity and producing the reduction in social anxiety and increase in trust that characterize oxytocin's well-documented prosocial effects. It also interacts with the dopamine reward system, the HPA axis stress response, and the neural circuits governing sexual arousal and orgasm.
Intranasal oxytocin — delivered via nasal spray — achieves central nervous system effects that intravenous administration doesn't produce to the same degree, because a proportion of intranasally delivered oxytocin reaches the brain via the olfactory and trigeminal nerve pathways rather than crossing the blood-brain barrier from systemic circulation. This route of administration is what makes clinical oxytocin therapy practical outside of an inpatient obstetric setting.
Magnolia prescribes compounded intranasal oxytocin at individualized doses, typically in the range of 20–40 IU administered before sexual activity or social situations where its effects are desired. Compounded formulations allow dose flexibility that the single FDA-approved IV oxytocin product (Pitocin, for labor induction) doesn't provide.
Why do We Use
Oxytocin
Oxytocin occupies an unusual position in hormone optimization medicine — it's not a deficiency state in the way that testosterone or thyroid hormone deficiency is, and there's no standard reference range for "optimal" oxytocin levels that guides prescribing the way a testosterone panel does. What the clinical literature does establish is that exogenous intranasal oxytocin produces consistent and measurable effects in specific domains — sexual function, anxiety reduction, social bonding, orgasm intensity — and that these effects are clinically meaningful for a subset of patients.
The sexual function data is the most clinically actionable. Multiple studies have demonstrated that intranasal oxytocin administered before sexual activity increases orgasm intensity, arousal, and overall sexual satisfaction in both men and women. A 2012 randomized controlled trial published in Hormones and Behavior found significant improvements in sexual function scores in both sexes with intranasal oxytocin. The mechanism involves oxytocin's action on hypothalamic and limbic circuits governing desire and arousal, its facilitation of dopamine release in reward pathways, and direct peripheral effects on genital smooth muscle that enhance erogenous sensitivity.
For women on hormone replacement therapy whose sexual function hasn't fully responded to estrogen and testosterone optimization, oxytocin addresses a neurobiological dimension of sexual response that sex steroids don't directly modulate. For men on TRT whose testosterone is optimized but whose subjective experience of intimacy and emotional connection feels muted, oxytocin targets the relational and experiential dimension of sexual health that hormonal optimization alone doesn't always restore.
The anxiety and social cognition effects are secondary but clinically relevant — particularly for patients whose sexual function difficulties have an anxiety component, and for patients who describe feeling emotionally disconnected from partners despite physiologically intact sexual function.
Key Benefits of
Oxytocin
Addresses the Neurobiological Dimension That Sex Steroids Don't: Testosterone and estrogen optimize the hormonal foundation of sexual health. Oxytocin acts on the limbic and hypothalamic circuits governing desire intensity, orgasm quality, emotional connection, and the subjective experience of intimacy — a neurobiological layer that sex steroid optimization doesn't directly reach. For patients whose hormones are optimized but whose sexual experience doesn't fully reflect that, oxytocin fills a mechanistically distinct gap.
Evidence-Based Enhancement of Orgasm and Sexual Arousal: Multiple clinical studies have demonstrated that intranasal oxytocin administered before sexual activity increases orgasm intensity, arousal, and overall sexual satisfaction in both men and women. The mechanism is direct — oxytocin acts on hypothalamic and limbic arousal circuits, facilitates dopamine release in reward pathways, and has peripheral effects on genital sensitivity. This is established pharmacology, not wellness speculation.
Anxiolytic Effects That Break the Performance Anxiety Cycle: Oxytocin reduces amygdala reactivity to social and performance threat — interrupting the anticipatory anxiety cycle that suppresses sexual arousal and function in patients with performance anxiety. For patients whose difficulties have a significant anxiety component, oxytocin approaches the problem neurologically rather than just pharmacologically compensating for the downstream effect.
HPA Axis Modulation for Stress-Related Libido Suppression: Chronic stress elevates cortisol, suppresses sex hormone production, and creates the sustained sympathetic tone that's directly antagonistic to sexual arousal. Oxytocin has documented HPA axis inhibitory effects — reducing cortisol stress response and dampening the chronic sympathetic activation that stress-related libido suppression depends on. For patients whose sexual health has declined alongside chronic stress, this mechanism is clinically relevant.
Intranasal Route — Practical CNS Delivery: Intranasal oxytocin reaches the central nervous system via olfactory and trigeminal pathways, achieving the limbic and hypothalamic effects that make it clinically useful in an outpatient context. The nasal spray is convenient, self-administered, and produces its effects within 15–30 minutes of use — practical for the sexual health applications where timing matters.
Prescribed in Clinical Context — Not Added Reflexively: Dr. Abdullah prescribes oxytocin as part of a complete hormonal evaluation, not as a standalone product. For patients who've already optimized their foundational hormonal picture and have a specific clinical goal that maps to oxytocin's established mechanisms, the addition is clinically rational and well-characterized. For patients who haven't optimized the foundation first, that's where the work starts.
Who Benefits Most From
Oxytocin
Women with Persistent Sexual Dysfunction Despite HRT: Women who've optimized estrogen, progesterone, and testosterone through hormone replacement therapy but still experience reduced arousal, difficulty achieving orgasm, or diminished subjective pleasure from sexual activity represent the most clinically compelling case for oxytocin. The sex steroids restore the physiologic foundation — vaginal health, lubrication, libido — but don't directly address the central neural circuits governing arousal intensity and orgasm quality. Oxytocin acts on exactly those circuits. For women who feel like their hormones are optimized on paper but their sexual experience doesn't reflect that, oxytocin fills a neurobiological gap that estrogen and testosterone don't reach.
Men on TRT Seeking Enhanced Intimacy and Sexual Experience: Testosterone replacement restores libido, erectile function, and physical drive — but some men on TRT describe a subjective flatness to their sexual experience that's difficult to articulate. The physical mechanics work, but the emotional depth and intensity of intimacy feels reduced compared to earlier in life. This disconnection between functional sexual performance and the relational quality of intimacy is exactly what oxytocin's central mechanism addresses. Its action on limbic reward circuitry and pair-bonding neurochemistry targets the experiential and relational dimension of sexuality that testosterone doesn't modulate directly. Men who are hormonally optimized but want the full emotional texture of intimacy restored are candidates for consideration.
Patients with Performance Anxiety Affecting Sexual Function: Sexual performance anxiety creates a self-perpetuating cycle: anticipatory anxiety activates the sympathetic nervous system, which directly inhibits the parasympathetically driven erectile and arousal responses, producing the outcome the patient feared, which amplifies anxiety for future encounters. Oxytocin's anxiolytic effects through amygdala modulation interrupt this cycle at the neurological level — reducing anticipatory threat response and allowing the parasympathetic tone that sexual function requires. For patients whose ED or arousal difficulties have a significant anxiety component that PDE5 inhibitors or hormonal optimization haven't fully addressed, oxytocin approaches the problem from a different mechanistic angle.
Couples Seeking Enhanced Connection and Intimacy: Some patients — both men and women — describe their primary concern not as a specific sexual dysfunction but as a felt reduction in emotional connection and intimacy with their partner. The bonding and trust-enhancing effects of oxytocin are among the most consistently demonstrated in the clinical literature, and the application of those effects to intimate relationships has biological plausibility even if the "relationship enhancement" framing isn't how academic oxytocin research is typically conducted. Dr. Abdullah discusses this application honestly — acknowledging what the evidence does and doesn't support — for patients where the relational dimension of sexuality is their primary concern.
Patients with Stress-Related Libido Suppression: Chronic stress produces sustained HPA axis activation — elevated cortisol suppresses GnRH pulsatility, reducing testosterone and libido in both sexes, and the chronic sympathetic nervous system tone that stress produces is directly antagonistic to sexual arousal and response. Oxytocin has documented HPA axis inhibitory effects — it reduces cortisol response to stressors and dampens the sympathetic activation that chronic stress produces. For patients whose libido and sexual satisfaction have declined in the context of chronically elevated stress loads, oxytocin addresses the neuroendocrine mechanism rather than just the hormonal downstream effects.
What To Expect From
Oxytocin
Step 1 — Hormonal Evaluation: Dr. Abdullah reviews your complete hormonal picture before considering oxytocin — testosterone, estrogen, progesterone, thyroid, cortisol if indicated. For patients already established in Dr. Abdullah's hormone optimization program with current labs, this step is largely already done. For new patients, labs are ordered at the initial consultation.
Step 2 — Clinical Discussion: The oxytocin conversation is about expectations and mechanism — what it does, how it does it, what clinical goals it's appropriate for, and how it fits into your broader protocol. This is a physician conversation, not a product pitch. Dr. Abdullah discusses what the evidence supports and what it doesn't, and prescribes oxytocin when the clinical picture genuinely indicates it rather than reflexively adding it to every hormone protocol.
Step 3 — Compounded Intranasal Prescription: Oxytocin is prescribed as a compounded intranasal spray at an individualized dose — typically 20–40 IU. The spray is used before sexual activity or social situations where its effects are desired, typically 15–30 minutes before. Dosing is adjusted based on your response.
Step 4 — Follow-Up and Integration: Oxytocin is managed as part of your overall hormone optimization follow-up at Magnolia. Response assessment at 4–8 weeks — subjective improvements in the domains it's intended to address — guides whether the dose or timing needs adjustment.
Is
Oxytocin
right for me?
Oxytocin therapy is most appropriate for patients who've already optimized the foundational hormonal picture — sex steroids, thyroid, metabolic health — and are looking for the next layer of sexual health optimization. Prescribing oxytocin before addressing low testosterone, estrogen deficiency, or significant thyroid dysfunction puts the cart before the horse. Dr. Abdullah evaluates the complete hormonal picture before adding oxytocin to a protocol.
It's also most appropriate for patients with a specific goal that maps to oxytocin's established mechanisms — enhanced orgasm and arousal, reduced performance anxiety, improved emotional connection alongside sexual function. It's not a general aphrodisiac or a solution for ED with a primarily vascular cause.
Oxytocin is generally well-tolerated intranasally. Side effects at clinical doses are mild and infrequent — occasional mild headache, nausea, or nasal irritation. There are no clinically significant drug interactions at intranasal doses. The primary contraindication is pregnancy beyond the context of medically supervised labor, where exogenous oxytocin affects uterine contractility. Dr. Abdullah reviews reproductive status and intent before prescribing for women of childbearing age.
Oxytocin Therapy at Magnolia Functional Wellness — Southlake, TX
Most of the sexual health conversation in functional medicine focuses on hormones — testosterone, estrogen, progesterone — and for good reason. Those are the foundational deficiencies. But there's a category of patient who arrives at Magnolia with testosterone optimized, estrogen and progesterone balanced, libido technically restored, and still describes something missing from their intimate life that no lab panel captures. The orgasms aren't as intense as they were. The emotional depth of sex feels flatter than the numbers would suggest it should. Performance anxiety persists even when the physiology is working. Sex steroids restored the biological infrastructure of sexual function. They didn't touch the limbic and hypothalamic circuitry governing desire intensity, bonding, and orgasm quality — because that circuitry operates through a different neurochemical system entirely. That's the system oxytocin acts on.
The Neuroscience: Why "Love Hormone" Sells It Short
The popular label captures the pair-bonding story while obscuring the mechanisms that are clinically useful. What the research literature on intranasal oxytocin has established over two decades is a specific set of CNS effects that nothing else in the sexual health toolkit produces.
The most clinically important is amygdala modulation. The amygdala is the brain's threat-detection center — and in the context of sexual function, amygdala hyperactivation is one of the most reliable inhibitors of the parasympathetic tone that arousal and erection depend on. Performance anxiety, anticipatory fear, the self-monitoring that progressively worsens sexual function the more consciously someone tries to address it — these are amygdala-driven phenomena. Oxytocin reduces amygdala reactivity to threat and social cues with remarkable consistency in the research literature, a finding replicated across dozens of studies in healthy volunteers and clinical populations. This is mechanistically upstream from what a PDE5 inhibitor does. Sildenafil compensates for vascular insufficiency caused by sympathetic tone. Oxytocin reduces the anxiety generating that tone in the first place. For patients where anxiety is a meaningful driver of their sexual difficulties, that's the difference between addressing a symptom and addressing its cause.
Alongside the anxiolytic mechanism, oxytocin modulates the mesolimbic dopamine system — the brain's reward and salience circuitry — in ways that enhance the subjective intensity and emotional value of intimacy. A 2012 randomized controlled trial published in Hormones and Behavior demonstrated statistically significant improvements in orgasm intensity, arousal, and overall sexual satisfaction in both men and women receiving intranasal oxytocin versus placebo before sexual activity. A 2013 study in the same journal documented specifically enhanced orgasm intensity in men. These aren't isolated positive findings in an otherwise equivocal literature — they're consistent with the mechanistic understanding of oxytocin's role in the hypothalamic-pituitary axis regulation of sexual response and pair-bonding behavior. Dr. Abdullah draws on this literature specifically when evaluating oxytocin candidacy.
Why the Intranasal Route Isn't Just a Delivery Convenience
The FDA-approved oxytocin product is Pitocin — an IV formulation for labor induction and postpartum hemorrhage management. When oxytocin is administered intravenously, it produces pronounced peripheral effects (uterine contractions, vascular tone changes) but limited CNS penetration, because the peptide crosses the blood-brain barrier poorly from systemic circulation. This is the formulation that produces the obstetric effects everyone associates with oxytocin.
The intranasal route works through an entirely different mechanism. Intranasally delivered peptides reach the brain directly via olfactory epithelium and trigeminal nerve pathways — bypassing the blood-brain barrier entirely and achieving concentrations in the limbic system and hypothalamus that systemic delivery doesn't produce at clinical doses. This isn't a workaround or an approximation of IV delivery. It's pharmacologically the correct route for the CNS effects being targeted. The entire body of research on oxytocin's amygdala modulation, social cognition, and sexual function used the intranasal route specifically because that's the route that delivers oxytocin to where those effects originate.
Compounded intranasal oxytocin at Magnolia — typically 20–40 IU administered 15–30 minutes before sexual activity — draws on the same mechanism and the same clinical literature. Dosing is individualized based on your response. Most patients notice effects within 15–30 minutes of administration: a qualitative reduction in anxiety, heightened emotional sensitivity, and the enhanced arousal and orgasm intensity that the RCT data documents. The effect is subtle at clinical doses — not a drug sensation, not euphoria — which is why some patients need several uses to distinguish it from placebo and why realistic expectations are part of every prescribing conversation.
The Specific Patients for Whom This Is the Right Recommendation
The clinical picture that makes oxytocin genuinely indicated at Magnolia is specific enough to be worth describing in detail, because oxytocin prescribed outside of it tends to underdeliver.
Women who've been through comprehensive HRT — estrogen optimized, progesterone balanced, testosterone added, vaginal atrophy addressed, genitourinary health restored — and still report that something is off. Arousal is slower than it used to be. Orgasm intensity has declined from what it was earlier in life even though the hormonal picture looks good. The emotional texture of sex — the sense of connection and intensity that once came without effort — feels attenuated in a way that's hard to articulate to a physician. Sex steroids restored the physiologic foundation. They don't directly modulate the limbic circuits governing desire intensity and the subjective quality of orgasm. Oxytocin addresses that neurobiological layer specifically, and because the mechanisms don't overlap, the effects are additive rather than redundant to the HRT already in place.
Men on TRT with testosterone fully optimized — libido returned, erectile function solid, energy and mood improved — who nonetheless describe something harder to pin down. The mechanics are working, but the emotional depth of intimacy feels muted compared to how it used to be. Sex is physically functional but somehow doesn't feel as meaningful or connected as it once did. That's not a testosterone problem. It's a limbic bonding circuitry problem, and adjusting the testosterone dose doesn't fix it. Dr. Abdullah has these conversations directly, because naming what a patient is experiencing and having a biologically rational intervention for it is meaningfully different from telling them their labs look fine.
The third profile is the patient where anxiety is clearly the primary driver — the person whose sexual difficulties have progressively worsened the harder they've tried to consciously address them. The cycle is familiar: anticipatory fear of poor performance produces exactly the outcome feared, which increases anxiety before the next encounter, which makes the outcome worse. This cycle is self-reinforcing and doesn't respond to the willpower-based approaches most people try first. No other pharmacologic tool in the sexual health toolkit specifically targets the amygdala activation that drives it. Oxytocin does — mechanistically and specifically — and for this patient profile, it's often the intervention that breaks the cycle rather than managing its downstream effects.
Sequence Matters: Foundation Before Fine-Tuning
Dr. Abdullah is direct about where oxytocin belongs in a treatment sequence. A man with testosterone of 180 ng/dL doesn't need a neurobiological fine-tuning agent. He needs testosterone restored, and adding an upstream limbic modulator to an unresolved hormonal deficiency produces proportionally limited results. The foundational hormonal work has to be done first — testosterone optimized, estrogen and progesterone balanced, thyroid addressed if relevant — because the neurobiological layer oxytocin targets sits on top of a physiologic foundation, not around it.
This means patients who arrive at Magnolia requesting oxytocin before their foundational hormonal picture has been evaluated or optimized are told that sequence honestly. That's not a barrier to access. It's the clinical reasoning behind why oxytocin produces the outcomes the research documents: the studies showing improved orgasm intensity and sexual satisfaction were conducted in patients without significant untreated hormonal deficiency. Replicating those outcomes requires the same foundational starting point.
Patients already established in Magnolia's TRT or women's HRT programs reach the oxytocin evaluation point naturally as part of ongoing optimization. For new patients, the intake that precedes any oxytocin recommendation includes the hormonal evaluation that determines where in the sequence they are and what needs to be in place before adding this layer.
Regulatory Transparency and Safety
Pitocin is the only FDA-approved oxytocin product, indicated for obstetric use via IV administration. Intranasal oxytocin for sexual function is prescribed off-label through 503A compounding pharmacies — a category of clinical practice that's legal, common in functional and integrative medicine, and built on legitimate published evidence, but that every patient at Magnolia understands fully before any prescription is written. The regulatory status, the evidence base, and what those things mean for your clinical decision are part of every consultation, not disclosed in the fine print.
Side effects at clinical intranasal doses are minimal: occasional mild headache or transient nasal irritation, with no clinically significant drug interactions documented at therapeutic doses. Women of reproductive age receive a specific discussion of oxytocin's uterotonic mechanism before prescribing — the peripheral uterine stimulation that IV oxytocin produces is not expected from intranasal delivery at clinical doses, but the conversation is appropriate and happens every time. Patients who are pregnant do not receive this prescription.
Magnolia serves patients seeking oxytocin therapy from Southlake, Westlake, Colleyville, Grapevine, Keller, Trophy Club, Flower Mound, and across the DFW Metroplex. For established TRT and HRT patients, oxytocin evaluation is incorporated into follow-up visits when the foundational hormonal work is complete.
How Process Works at
Magnolia Functional Wellness
Assess
We begin with a comprehensive evaluation of your health, goals, and medical background to understand the root causes, not just the symptoms.
Personalize
Based on your results, we create a tailored functional wellness plan using evidence-based therapies designed specifically for your body and needs.
Optimize
Through ongoing care, monitoring, and adjustments, we help you achieve sustainable improvements in performance, vitality, and long-term health.
Addresses the Neurobiological Dimension That Sex Steroids Don't
Testosterone and estrogen optimize the hormonal foundation of sexual health. Oxytocin acts on the limbic and hypothalamic circuits governing desire intensity, orgasm quality, emotional connection, and the subjective experience of intimacy — a neurobiological layer that sex steroid optimization doesn't directly reach. For patients whose hormones are optimized on paper but whose sexual experience doesn't fully reflect that, oxytocin fills a mechanistically distinct gap.
Evidence-Based Enhancement of Orgasm and Sexual Arousal
Multiple clinical studies including a randomized controlled trial in Hormones and Behavior have demonstrated that intranasal oxytocin administered before sexual activity increases orgasm intensity, arousal, and overall sexual satisfaction in both men and women. The mechanism is direct — oxytocin acts on hypothalamic and limbic arousal circuits, facilitates dopamine release in reward pathways, and has peripheral effects on genital sensitivity. This is established pharmacology, not wellness speculation.
Anxiolytic Effects That Break the Performance Anxiety Cycle
Oxytocin reduces amygdala reactivity to social and performance threat — interrupting the anticipatory anxiety cycle that suppresses sexual arousal and function in patients with performance anxiety. For patients whose difficulties have a significant anxiety component, oxytocin approaches the problem neurologically rather than just pharmacologically compensating for the downstream effect.
HPA Axis Modulation for Stress-Related Libido Suppression
Chronic stress elevates cortisol, suppresses sex hormone production, and creates the sustained sympathetic tone that's directly antagonistic to sexual arousal. Oxytocin has documented HPA axis inhibitory effects — reducing cortisol stress response and dampening the chronic sympathetic activation that stress-related libido suppression depends on. For patients whose sexual health has declined alongside chronic stress, this mechanism is clinically relevant.
Intranasal Route — Practical CNS Delivery
Intranasal oxytocin reaches the central nervous system via olfactory and trigeminal pathways, achieving the limbic and hypothalamic effects that make it clinically useful in an outpatient context. The nasal spray is convenient, self-administered, and produces its effects within 15–30 minutes of use — practical for the sexual health applications where timing matters.
Prescribed in Clinical Context — Not Added Reflexively
Dr. Abdullah prescribes oxytocin as part of a complete hormonal evaluation, not as a standalone product. For patients who've already optimized their foundational hormonal picture and have a specific clinical goal that maps to oxytocin's established mechanisms, the addition is clinically rational and well-characterized. For patients who haven't optimized the foundation first, that's where the work starts.
Your Questions Answered
Led by trained medical professionals delivering safe, effective, and scientifically backed aesthetic and wellness treatments.
Is oxytocin FDA-approved for sexual function?
The only FDA-approved oxytocin product (Pitocin) is indicated for labor induction and postpartum hemorrhage — it's an IV formulation not used in outpatient hormone optimization. Intranasal oxytocin for sexual function is prescribed off-label from compounding pharmacies. Dr. Abdullah discusses the regulatory status, the evidence base, and what that means for your clinical decision clearly at consultation.
How do I take it?
Intranasal oxytocin is a nasal spray — typically one or two sprays (10–20 IU per spray) administered 15–30 minutes before sexual activity or the situation where you want its effects. The onset is relatively quick due to the direct CNS delivery pathway of the intranasal route.
Will I feel it immediately?
Most patients notice effects within 15–30 minutes of intranasal administration. The effects are subtle rather than dramatic — reduced anxiety, heightened emotional sensitivity, enhanced arousal and orgasm intensity. It doesn't produce euphoria or an obvious drug effect at clinical doses. Some patients need a few uses to notice consistent effects.
Can men use oxytocin?
Yes. The sexual function and anxiolytic effects of intranasal oxytocin have been demonstrated in both sexes. Men on TRT who want enhanced emotional depth in their intimate relationships, men with performance anxiety, and men seeking improved orgasm quality are all appropriate candidates for evaluation.
Does it work for everyone?
No — and Dr. Abdullah won't tell you otherwise. Oxytocin works most reliably for patients with a specific presentation that maps to its established mechanisms. For patients with primarily organic sexual dysfunction — vascular ED, hormonal deficiency, structural issues — oxytocin is not the right primary intervention. It's a targeted neurobiological add-on for the right clinical presentation, not a universal sexual health enhancer.
How much does it cost?
Compounded intranasal oxytocin is reasonably priced through our compounding pharmacy partners. Consultation and prescription pricing is available at the front desk. We don't bill insurance for hormone optimization services. HSA and FSA cards are accepted.
Need More Information?
Our team is ready to answer your specific questions and concerns.
Redefine Your Glow. Reimagine Your Life.
Led by trained medical professionals delivering safe, effective, and scientifically backed aesthetic and wellness treatments.
Not what you were looking
for? Explore More.
At Magnolia Functional Wellness, every treatment is guided by medical science, regenerative principles, and individualized care. We focus on restoring physiology at its source, enhancing vitality, and supporting long term health with evidence based interventions that go beyond traditional aesthetics.
Magnolia Functional Wellness is a physician-led clinic in Southlake, Texas specializing in advanced hormone optimization, medical weight loss, and regenerative therapies. Our most requested services include testosterone replacement therapy, women's hormone replacement therapy, medical weight loss, ketamine therapy, aesthetics, and regenerative medicine, each personalized and medically supervised to ensure safety, effectiveness, and long-term results.
